Retractions Often Due to Plagiarism: Study

The number of plagiarism-based retractions has grown since the advent of detection software, according to a BioMed Central analysis.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, VICTORFLISCORNOPlagiarism is the most common cause of retractions in BioMed Central journals, accounting for a quarter of cases documented, according to a poster presentation at the World Conference on Research Integrity being held in Rio de Janeiro this week. The authors found that the increase in plagiarism-related retractions rose after 2009, when plagiarism-detection software became more widely used.

“It was a bit unexpected because I don’t think this is the number-one reason that comes up in other studies,” said study coauthor Maria Kowalczuk, the biology editor in the Research Integrity Group at BioMed Central.

For instance, a 2012 PNAS study that analyzed more than 2,000 PubMed-indexed retractions found that fraud was responsible for 43 percent of retractions and plagiarism for 10 percent.

Plagiarism “has become easier to detect,” Kowalczuk told The Scientist. “Before 2009, it was mostly problems with duplicate publications and coauthors not being aware that the article was being published.”

Kowalczuk and Elizabeth Moylan, the senior editor of the Research Integrity Group, surveyed nearly 163,000 articles published between 2000 and 2014 by BioMed Central, which puts out 281 open-access journals. Among ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies